TrialThe Lancet. Rheumatology2024

Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial.

Jennifer S Hanberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.